Effects of liver disease and of aging on the disposition and elimination of sedatives.
作者信息
Schenker S
出版信息
Trans Am Clin Climatol Assoc. 1978;89:91-9.
Abstract
摘要
相似文献
1
Effects of liver disease and of aging on the disposition and elimination of sedatives.
Trans Am Clin Climatol Assoc. 1978;89:91-9.
2
The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam and lorazepam in man.
Acta Psychiatr Scand Suppl. 1978(274):56-74. doi: 10.1111/j.1600-0447.1978.tb02388.x.
3
Disposition and elimination of minor tranquilizers in the aged and in patients with liver disease.
South Med J. 1978 Aug;71 Suppl 2:23-8. doi: 10.1097/00007611-197808001-00006.
4
Effects of aging and liver disease on disposition of lorazepam.
Clin Pharmacol Ther. 1978 Oct;24(4):411-9. doi: 10.1002/cpt1978244411.
5
[Therapeutic notes: benzodiazepines].
Clin Ter. 1976 Dec 15;79(5):461-89.
6
Clinical pharmacokinetics of oxazepam and lorazepam.
Clin Pharmacokinet. 1981 Mar-Apr;6(2):89-105. doi: 10.2165/00003088-198106020-00001.
7
Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines.
Hepatology. 1983 Mar-Apr;3(2):248-53. doi: 10.1002/hep.1840030219.
8
[Pharmacokinetic of benzodiazepines in old age].
Schweiz Med Wochenschr. 1981 Nov 21;111(47):1789-93.
9
The effect of parenchymal liver disease on the disposition and elimination of sedatives and analgesics.
Med Clin North Am. 1975 Jul;59(4):887-96. doi: 10.1016/s0025-7125(16)31987-3.
10
The use of benzodiazepines in clinical practice.
Br J Clin Pharmacol. 1981;11 Suppl 1(Suppl 1):5S-9S. doi: 10.1111/j.1365-2125.1981.tb01832.x.
引用本文的文献
1
Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal.
CNS Drugs. 2017 Feb;31(2):87-95. doi: 10.1007/s40263-016-0403-y.
本文引用的文献
1
VARIATION IN THE ACTIVITY OF LIVER MICROSOMAL DRUG-METABOLIZING ENZYMES IN RATS IN RELATION TO THE AGE.
Biochem Pharmacol. 1964 Jul;13:1037-51. doi: 10.1016/0006-2952(64)90100-5.
2
Metabolism of drugs in subjects with Laennec's cirrhosis.
Med Exp Int J Exp Med. 1959;1:290-2. doi: 10.1159/000134806.
3
[Pharmacokinetics of meprobamate in chronic liver diseases and drug addiction].
Klin Wochenschr. 1969 Jan 15;47(2):78-80. doi: 10.1007/BF01745770.
4
Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis.
Clin Sci. 1972 Aug;43(2):143-51. doi: 10.1042/cs0430143.
5
Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age.
N Engl J Med. 1973 Feb 8;288(6):277-80. doi: 10.1056/NEJM197302082880602.
6
Changes in hepatic circulation at rest, during and after exercise in young males with infectious hepatitis compared with controls.
Acta Med Scand. 1974 Oct;196(4):315-25. doi: 10.1111/j.0954-6820.1974.tb01017.x.
7
The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
J Clin Invest. 1975 Feb;55(2):347-59. doi: 10.1172/JCI107938.
8
Intravenous administration of diazepam in patients with chronic liver disease.
Gut. 1976 Dec;17(12):975-83. doi: 10.1136/gut.17.12.975.
9
Comparison of the pharmacokinetics of diazepam after single and subchronic doses.
Eur J Clin Pharmacol. 1976 Jun 15;10(2):121-6. doi: 10.1007/BF00609470.
10
Benzodiazepine receptor: demonstration in the central nervous system.
Science. 1977 Nov 25;198(4319):849-51. doi: 10.1126/science.918669.
Zotero 插件